Thyroid Cancer Incidence and Risk Factors in Toxic Nodular Goiter Patients in a TertiaryCare Hospital
Abstract
Objective: In this specific research, patients with toxic nodular goiters were examined to determine the frequency and potential risk factors for malignant thyroid disease.Methods
In this research, 98 patients with toxic nodular goiter, which includes both single toxic nodules (STN) and toxic multinodular goiter (TMNG), were examined. Gender, age, comorbidities, prior neck radiation, family history of thyroid cancer, type of disease, size of the largest nodule as determined by ultrasound, surgery's duration, and identification of a lymph node during surgery were some of the patient characteristics that the research gathered. The patients were divided into groups with benign and malignant conditions based on the results of the histopathological investigation.Results
21 people (21.43%) of the 98 TNG patients had a malignant thyroid disease diagnosis. Both the benign and malignant groups had a comparable age distribution, but males had a significantly higher likelihood of developing cancer. In contrast, TMNG was more prevalent in the malignant group. Medical problems and family histories of cancer were equally prevalent in both groups. No discernible differences between the two groups were found in the operational statistics, including operative time and lymph node detection. Male gender and TMNG appeared to be key indicators of malignancy in regression analysis. These results imply that the danger of malignant thyroid disease in patients with TNG can be anticipated by the male gender and TMNG, two important factors.Conclusion
According to the research, malignant thyroid disease was found in 21.43 percent of TNG patients, indicating that thyroid hyperfunction does not offer protection against cancer. Additionally, these patients' MNG levels and being male were major risk factors for malignancy.Keywords:
Case-control study, Breast carcinoma, Risk factors, lifestyle, socio-demographic, Pakistan, and reproductive health.Published
2023/09/25
Issue
This work is licensed under a Creative Commons Attribution 4.0 International License.
This is an open-access journal and all the published articles / items are distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. For comments psimjournal@gmail.com